Comparison Between CHF5993 pMDI 200/6/12.5 µg HFA-152a VS CHF5993 pMDI 200/6/12.5 µg HFA-134a in Subjects With Asthma (TRECOS).

Conditions

• Asthma

Interventions

• DRUG: CHF5993 200/6/12.5 μg pMDI HFA-152a
• DRUG: Inhaler CHF5993 200/6/12.5 μg pMDI HFA-134a

Sponsor

Chiesi Farmaceutici S.p.A.